Abstract | BACKGROUND: METHODS: RESULTS:
Tumor reduction following NACRT was significantly attenuated in pre-therapeutic biopsy specimens associated with high HO-1 status. TXNRD1Δ, HO-1Δ, and 8-OHdGΔ were significantly different in the ineffective and effective groups. The overall survival was significantly lower in high Nrf2 and TXNRD1 groups. In addition, high TXNRD1 expression was an independent prognostic factor in the multivariate analysis of overall survival. CONCLUSIONS: The study findings indicate that HO-1 status in pre-therapeutic biopsy specimens could predict response to NACRT, and TXNRD1 status could predict overall survival of ESCC patients.
|
Authors | Ryujiro Akaishi, Fumiyoshi Fujishima, Hirotaka Ishida, Junichi Tsunokake, Takuro Yamauchi, Yusuke Gokon, Shunsuke Ueki, Toshiaki Fukutomi, Hiroshi Okamoto, Kai Takaya, Chiaki Sato, Yusuke Taniyama, Tomohiro Nakamura, Naoki Nakaya, Takashi Kamei, Hironobu Sasano |
Journal | Esophagus : official journal of the Japan Esophageal Society
(Esophagus)
Vol. 19
Issue 3
Pg. 436-443
(07 2022)
ISSN: 1612-9067 [Electronic] Japan |
PMID | 34999996
(Publication Type: Journal Article)
|
Copyright | © 2022. The Author(s). |
Chemical References |
- NF-E2-Related Factor 2
- HMOX1 protein, human
- Heme Oxygenase-1
- TXNRD1 protein, human
- Thioredoxin Reductase 1
|
Topics |
- Esophageal Neoplasms
(drug therapy, radiotherapy)
- Esophageal Squamous Cell Carcinoma
(drug therapy, pathology)
- Heme Oxygenase-1
(genetics, therapeutic use)
- Humans
- NF-E2-Related Factor 2
(therapeutic use)
- Neoadjuvant Therapy
- Thioredoxin Reductase 1
(genetics)
|